FREELINE THERAPEUTICS HOLDIN (FRLN)

US35655L2060 - ADR

6.48  0 (0%)

After market: 6.48 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
625.00K0.000.000.000.00
Cost Of Goods
N/AN/AN/AN/A25.51M
Gross Profit
N/AN/AN/AN/A-25.51M
Operating Expenses
67.80M96.86M140.00M102.45M38.13M
Research and Development
35.30M54.65M95.43M76.15M21.54M
Selling, General, and Administrative Expenses
32.50M42.21M44.57M26.30M16.60M
Operating Income
-67.17M-96.86M-140.00M-102.45M-63.64M
Interest Income/Expense
608.00K900.00K400.00K280.00K-130.00K
Other Income/Expense
-2.46M8.94M1.93M5.98M10.00M
Non Recurring Items
19.58M-1.59M-2.38MN/AN/A
Income Before Taxes
-49.46M-88.60M-140.05M-96.19M-53.77M
Income Tax
481.00K370.00K340.00K130.00K140.00K
Net Income
-49.93M-88.97M-140.39M-96.32M-53.91M
EBITDA
-65.72M-95.12M-137.61M-100.54M-62.10M
 
Per Share Data
EPS Diluted Total Ops
-133.73-337.81-884.73-604.37-348.46
Non GAAP EPS
N/A-25.95-17.36N/AN/A
 
Statistics
Profit Margin
-7988.48%N/AN/AN/AN/A
Operating Profit Margin
-10747.68%N/AN/AN/AN/A

All data in USD

Charts